{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:41Z","timestamp":1778858801463,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,16]]},"DOI":"10.7759\/cureus.58387","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T13:22:16Z","timestamp":1713273736000},"source":"Crossref","is-referenced-by-count":2,"title":["Gonadotropin-Releasing Hormone (GnRH) Agonists Do Not Protect Ovarian Function in Patients Undergoing Stem Cell Transplants"],"prefix":"10.7759","author":[{"given":"Ariel","family":"Benor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Decherney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1191\/096120300678828596","article-title":"Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy","volume":"9","author":"Blumenfeld Z","year":"2000","unstructured":"Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus. 2000, 9:401-5. 10.1191\/096120300678828596","journal-title":"Lupus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow D","year":"2010","unstructured":"Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010, 53:727-39. 10.1097\/GRF.0b013e3181f96b54","journal-title":"Clin Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.05.008","article-title":"Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases","volume":"41","author":"Blumenfeld Z","year":"2011","unstructured":"Blumenfeld Z, Mischari O, Schultz N, Boulman N, Balbir-Gurman A. Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases. Semin Arthritis Rheum. 2011, 41:346-52. 10.1016\/j.semarthrit.2011.05.008","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.12.001","article-title":"Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials","volume":"40","author":"Del Mastro L","year":"2014","unstructured":"Del Mastro L, Ceppi M, Poggio F, et al.. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014, 40:675-83. 10.1016\/j.ctrv.2013.12.001","journal-title":"Cancer Treat Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002019","article-title":"Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis","volume":"29","author":"Li ZY","year":"2022","unstructured":"Li ZY, Dong YL, Cao XZ, Ren SS, Zhang Z. Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis. Menopause. 2022, 29:1093-100. 10.1097\/GME.0000000000002019","journal-title":"Menopause"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial","volume":"117","author":"Sverrisdottir A","year":"2009","unstructured":"Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009, 117:561-7. 10.1007\/s10549-009-0313-5","journal-title":"Breast Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9745-y","article-title":"Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)","volume":"110","author":"Urruticoechea A","year":"2008","unstructured":"Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE. Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat. 2008, 110:411-16. 10.1007\/s10549-007-9745-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000905","article-title":"Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis","volume":"126","author":"Elgindy E","year":"2015","unstructured":"Elgindy E, Sibai H, Abdelghani A, Mostafa M. Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis. Obstet Gynecol. 2015, 126:187-95. 10.1097\/AOG.0000000000000905","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.8185","article-title":"Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial","volume":"31","author":"Demeestere I","year":"2013","unstructured":"Demeestere I, Brice P, Peccatori FA, et al.. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol. 2013, 31:903-9. 10.1200\/JCO.2012.42.8185","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"29","author":"Gerber B","year":"2011","unstructured":"Gerber B, von Minckwitz G, Stehle H, et al.. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011, 29:2334-41. 10.1200\/JCO.2010.32.5704","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere I","year":"2016","unstructured":"Demeestere I, Brice P, Peccatori FA, et al.. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016, 34:2568-74. 10.1200\/JCO.2015.65.8864","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140842","article-title":"Chemotherapy-related amenorrhea and menopause in young Chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles","volume":"10","author":"Liem GS","year":"2015","unstructured":"Liem GS, Mo FK, Pang E, et al.. Chemotherapy-related amenorrhea and menopause in young Chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles. PLoS One. 2015, 10:e0140842. 10.1371\/journal.pone.0140842","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-02039-8","article-title":"Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases","volume":"22","author":"Wang Z","year":"2022","unstructured":"Wang Z, An J, Wang C. Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases. BMC Womens Health. 2022, 22:436. 10.1186\/s12905-022-02039-8","journal-title":"BMC Womens Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","author":"American Society for Reproductive Medicine","year":"2019","unstructured":"American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019, 112:1022-33. 10.1016\/j.fertnstert.2019.09.013","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/7.6.535","article-title":"The effects of radiotherapy and chemotherapy on female reproduction","volume":"7","author":"Meirow D","year":"2001","unstructured":"Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001, 7:535-43. 10.1093\/humupd\/7.6.535","journal-title":"Hum Reprod Update"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000451757.51964.98","article-title":"Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women","volume":"124","year":"2014","unstructured":"Committee opinion no. 605. primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014, 124:193-7. 10.1097\/01.AOG.0000451757.51964.98","journal-title":"Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al.. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green DM","year":"2014","unstructured":"Green DM, Nolan VG, Goodman PJ, et al.. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014, 61:53-67. 10.1002\/pbc.24679","journal-title":"Pediatr Blood Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgindy EA","year":"2013","unstructured":"Elgindy EA, El-Haieg DO, Khorshid OM, Ismail EI, Abdelgawad M, Sallam HN, Abou-Setta AM. Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial. Obstet Gynecol. 2013, 121:78-86. 10.1097\/aog.0b013e31827374e2","journal-title":"Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.2793","article-title":"Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer","volume":"24","author":"Walshe JM","year":"2006","unstructured":"Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol. 2006, 24:5769-79. 10.1200\/JCO.2006.07.2793","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.6890","article-title":"Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer","volume":"30","author":"Munster PN","year":"2012","unstructured":"Munster PN, Moore AP, Ismail-Khan R, et al.. Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol. 2012, 30:533-8. 10.1200\/JCO.2011.34.6890","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.02.003","article-title":"Sexuality- and fertility-related issues in women after allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Forgeard N","year":"2021","unstructured":"Forgeard N, Jestin M, Vexiau D, et al.. Sexuality- and fertility-related issues in women after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021, 27:432.e1-6. 10.1016\/j.jtct.2021.02.003","journal-title":"Transplant Cell Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/242458-gonadotropin-releasing-hormone-gnrh-agonists-do-not-protect-ovarian-function-in-patients-undergoing-stem-cell-transplants","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T13:22:20Z","timestamp":1713273740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/242458-gonadotropin-releasing-hormone-gnrh-agonists-do-not-protect-ovarian-function-in-patients-undergoing-stem-cell-transplants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.58387","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}